Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York I spent 4 months reporting on the peptide BPC 157 and its unlikely journey from a research lab in post communist Croatia to today's MAHA movement. Ask me anything. : r IAmA FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling